Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

18.04.2024 | case report

Masqueraded sebaceous gland carcinoma of the lower eyelid in a young pregnant patient

verfasst von: Karla Randelovic, MD, FEBO, Ivanka Petric Vickovic, MD, PhD, Valentina Lacmanovic Loncar, MD, PhD, Leo Pazanin, MD, PhD, Anita Pusic Sesar, MD, PhD, Renata Ivekovic, MD, PhD, Zoran Vatavuk, MD, PhD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 1-2/2025

Einloggen, um Zugang zu erhalten

Summary

The purpose of this case report is to present misdiagnosed sebaceous gland carcinoma of the lower eyelid with rapid growth in a young woman during pregnancy. Eyelid sebaceous gland carcinoma is a relatively rare tumor and a disease primarily of older patients. It occurs more commonly in oriental populations and with a predilection for the upper eyelid. Early diagnosis and appropriate treatment may help improve disease control and patient survival.
Vorheriger Artikel Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited
Nächster Artikel The value of cryoablation in orbital surgery
Literatur
1.
Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50:103–22.CrossRefPubMed
2.
Muqit MM, Foot B, Walters SJ, Mudhar H, Roberts F, Rennie IG. Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma. Br J Ophthalmol. 2013;97:47–51.CrossRefPubMed
3.
Owen JL, et al. Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA et al. Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol. 2019;20:e699–e714.CrossRefPubMed
4.
Takahashi Y, Takahashi E, Nakakura S, Kitaguchi Y, Mupas-Uy J, Kakizaki H. Risk Factors for Local Recurrence or Metastasis of Eyelid Sebaceous Gland Carcinoma After Wide Excision With Paraffin Section Control. Am J Ophthalmol. 2016;171:67–74.CrossRefPubMed
5.
Zhou C, Wu F, Chai P, Shi Y, Ye J, Shi X, et al. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients. J Am Acad Dermatol. 2019;80:1608–17.CrossRefPubMed
6.
While B, Salvi S, Currie Z, Mudhar HS, Tan JH. Excision and delayed reconstruction with paraffin section histopathological analysis for periocular sebaceous carcinoma. Ophthalmic Plast Reconstr Surg. 2014;30:105–9.CrossRefPubMed
7.
Kibbi N, Worley B, Owen JL, Kelm RC, Bichakjian CK, Chandra S, et al. Sebaceous carcinoma: controversies and their evidence for clinical practice. Arch Dermatol Res. 2020;312:25–23.CrossRefPubMed
8.
Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M, Sagiv O, et al. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients. Br J Ophthalmol. 2019;103:980–4.CrossRefPubMed
9.
Cho KJ, Khang KS, Koh JS, Chung JH, Lee SS. Sebaceous carcinoma of the eyelids: frequent expression of c‑erbB‑2 oncoprotein. J Korean Med Sci. 2000;15:545–50.CrossRefPubMedPubMedCentral
10.
Na HY, Choe JY, Shin SA, Choung HK, Oh S, Chung JH, et al. Proposal of a Provisional Classification of Sebaceous Carcinoma Based on Hormone Receptor Expression and HER2 Status. Am J Surg Pathol. 2016;40:1622–30.CrossRefPubMed
Metadaten
Titel
Masqueraded sebaceous gland carcinoma of the lower eyelid in a young pregnant patient
verfasst von
Karla Randelovic, MD, FEBO
Ivanka Petric Vickovic, MD, PhD
Valentina Lacmanovic Loncar, MD, PhD
Leo Pazanin, MD, PhD
Anita Pusic Sesar, MD, PhD
Renata Ivekovic, MD, PhD
Zoran Vatavuk, MD, PhD
Publikationsdatum
18.04.2024
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 1-2/2025
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-024-02349-x

Weitere Artikel der Ausgabe 1-2/2025

Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients

  • original article

Is location more determining than WHO grade for long-term clinical outcome in patients with meningioma in the first two decades of life?

  • Open Access
  • original article

Predictors of static and dynamic balance control in kidney transplant recipients

  • original article

12. Pneumo Aktuell

  • mitteilungen der österreichischen gesellschaft für pneumologie

Microplastics: Omnipresent and an ongoing challenge for medical science

  • Open Access
  • short report

Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency: correspondence

  • letter to the editors